Researchers from Massachusetts General Harvard, Dana Farber Cancer Institute and Brigham and Women’s Hospital recently revealed that long-term use of aspirin is associated with lower risk of dying from various types of cancers, including lung and prostate cancer. Both cancers are the leading killers of men. The findings were presented at the April 2017 meeting of the American Association for Cancer Research.
Apparently aspirin not only reduces the risk of developing… Read More »
Tagged with: American Cancer Society, annual physical, Bayer, diet and prostate cancer, enlarged prostate, Harvard Medical School, men who speak up, National Mens Health Awareness Initiative, PSA, US Preventative Services Taskforce, ZERO
Men who take aspirin regularly may have a lower risk of dying from prostate cancer, a new study suggests.
Dr. Christopher Allard, a urologic oncology fellow at Harvard Medical School in Boston reported that the regular intake of aspirin decreases the risk of prostate cancer death by almost 40%. That may suggest men could have one more reason to consider regular aspirin use.
The findings were presented Jan. Read More »
The National Prostate Cancer Awareness Foundation (PCaAWARE) is pleased to announce that the National Comprehensive Cancer Network® has published updated NCCN Guidelines for Patients® and NCCN Quick Guide™ sheet for Prostate Cancer.
The NCCN Guidelines for Patients®: Prostate Cancer were updated from the 2015 version to the 2016 version. Changes to the patient guide include new treatment options and modifications to molecular testing and the addition of mpMRI for active surveillance. The… Read More »
Tagged with: Bayer, enlarged prostate, men who speak up, National Mens Health Awareness Initiative, prostate cancer, prostate cancer awareness, prostate cancer diagnosis, real men speak up, silence is not a cure, understanding prostate cancer, US Preventative Services Taskforce, UsToo
In recognition of September as Prostate Cancer Awareness Month, PCaAWARE is pleased to share the following reminders.
— Prostate cancer is the second most common cancer among men, behind skin cancer, and affects one in seven men.
— Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer.
— In 2016 approximately 250,000 new cases will be diagnosed in the United States; about… Read More »
Some research suggests that drinking pomegranate juice may slow the progression of prostate cancer.
For example, in a study of men with recurrent prostate cancer and rising prostate-specific antigen (PSA) levels, researchers found that taking pomegranate juice extract significantly slowed the rate at which PSA was rising (PSA doubling time). A longer PSA doubling time can indicate that the cancer may be progressing less rapidly.
But this study did not… Read More »
Prostate cancer screening with prostate-specific antigen (PSA) has been shown to reduce death and the spread of prostate cancer to other parts of the body, but the PSA test remains highly controversial as it frequently leads to over diagnosis and over treatment of men who may not be at risk. Smarter screening strategies that can improve the accuracy of diagnosing lethal prostate cancer are urgently needed. Through a prospective… Read More »
Tagged with: African American Men, annual physical, Bayer, Brigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Mark Preston, MD, men who speak up, MPH, Physicians' Health Study, real men get tested, ZERO
Many studies have shown the negative effect health providers’ underlying prejudices can have on the doctor-patient relationship and the decisions patients make about their care. And according to a new study, oncologists are not immune.
Some cancer physicians are letting their implicit racial biases get in the way of quality treatment for Black patients.
Researchers at the Karmanos Cancer Institute in Detroit, Michigan, studied video-recorded interactions between 18… Read More »
Tagged with: Bayer, black patients, diet and prostate cancer, Harvard Medical School, JAMA Oncology, Journal of Clinical Oncology, Karmanos Cancer Institute, Louis A. Penner, men who speak up, Office of Minority Health, Quoc-Dien Trinh, real men get tested, Reuters, University of Colorado Cancer Center, ZERO